The Mayo Dysphagia Questionnaire-30: Documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease

Judith McElhiney, Matthew R. Lohse, Amindra S. Arora, Joanna M. Peloquin, Debra M. Geno, Melissa M. Kuntz, Felicity T Enders, Mary Fredericksen, Adil A. Abdalla, Yulia Khan, Nicholas J. Talley, Nancy N. Diehl, Timothy J. Beebe, Ann M. Harris, Gianrico Farrugia, Darlene E. Graner, Joseph A Murray, G. Richard Locke, Rayna M. Grothe, Michael D. CrowellDawn L. Francis, April M B Grudell, Tushar Dabade, Angelica Ramirez, Mhdmaan Alkhatib, Jeffrey A. Alexander, Jessica Kimber, Prasad G Iyer, Alan R. Zinsmeister, Yvonne Romero

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The aim of this study was to develop the Mayo Dysphagia Questionnaire-30 Day (MDQ-30), a tool to measure esophageal dysphagia, by adapting items from validated instruments for use in clinical trials, and assess its feasibility, reproducibility, and concurrent validity. Outpatients referred to endoscopy for dysphagia or seen in a specialty clinic were recruited. Feasibility testing was done to identify problematic items. Reproducibility was measured by test-retest format. Concurrent validity reflects agreement between information gathered in a structured interview versus the patients' written responses. The MDQ-30, a 28-item instrument, took 10 min (range = 5-30 min) to complete. Four hundred thirty-one outpatients [210 (49%) men; mean age = 61 years] participated. Overall, most concurrent validity κ values for dysphagia were very good to excellent with a median of 0.78 (min 0.28, max 0.95). The majority of reproducibility κ values for dysphagia were moderate to excellent with a median κ value of 0.66 (min 0.07, max 1.0). Overall, concurrent validity and reproducibility κ values for gastroesophageal reflux disease (GERD) symptoms were 0.81 (95% CI = 0.72, 0.91) and 0.66 (95% CI = 0.55, 0.77), respectively. Individual item percent agreement was generally very good to excellent. Internal consistency was excellent. We conclude that the MDQ-30 is an easy-to-complete tool to evaluate reliably dysphagia symptoms over the last 30 days.

Original languageEnglish (US)
Pages (from-to)221-230
Number of pages10
JournalDysphagia
Volume25
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Esophageal Diseases
Deglutition Disorders
Reproducibility of Results
Documentation
Outpatients
Surveys and Questionnaires
Gastroesophageal Reflux
Endoscopy
Clinical Trials
Interviews

Keywords

  • Concurrent validity
  • Deglutition
  • Deglutition disorders
  • Dysphagia
  • Questionnaire
  • Reproducibility

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Gastroenterology
  • Speech and Hearing

Cite this

The Mayo Dysphagia Questionnaire-30 : Documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. / McElhiney, Judith; Lohse, Matthew R.; Arora, Amindra S.; Peloquin, Joanna M.; Geno, Debra M.; Kuntz, Melissa M.; Enders, Felicity T; Fredericksen, Mary; Abdalla, Adil A.; Khan, Yulia; Talley, Nicholas J.; Diehl, Nancy N.; Beebe, Timothy J.; Harris, Ann M.; Farrugia, Gianrico; Graner, Darlene E.; Murray, Joseph A; Locke, G. Richard; Grothe, Rayna M.; Crowell, Michael D.; Francis, Dawn L.; Grudell, April M B; Dabade, Tushar; Ramirez, Angelica; Alkhatib, Mhdmaan; Alexander, Jeffrey A.; Kimber, Jessica; Iyer, Prasad G; Zinsmeister, Alan R.; Romero, Yvonne.

In: Dysphagia, Vol. 25, No. 3, 09.2010, p. 221-230.

Research output: Contribution to journalArticle

McElhiney, J, Lohse, MR, Arora, AS, Peloquin, JM, Geno, DM, Kuntz, MM, Enders, FT, Fredericksen, M, Abdalla, AA, Khan, Y, Talley, NJ, Diehl, NN, Beebe, TJ, Harris, AM, Farrugia, G, Graner, DE, Murray, JA, Locke, GR, Grothe, RM, Crowell, MD, Francis, DL, Grudell, AMB, Dabade, T, Ramirez, A, Alkhatib, M, Alexander, JA, Kimber, J, Iyer, PG, Zinsmeister, AR & Romero, Y 2010, 'The Mayo Dysphagia Questionnaire-30: Documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease', Dysphagia, vol. 25, no. 3, pp. 221-230. https://doi.org/10.1007/s00455-009-9246-8
McElhiney, Judith ; Lohse, Matthew R. ; Arora, Amindra S. ; Peloquin, Joanna M. ; Geno, Debra M. ; Kuntz, Melissa M. ; Enders, Felicity T ; Fredericksen, Mary ; Abdalla, Adil A. ; Khan, Yulia ; Talley, Nicholas J. ; Diehl, Nancy N. ; Beebe, Timothy J. ; Harris, Ann M. ; Farrugia, Gianrico ; Graner, Darlene E. ; Murray, Joseph A ; Locke, G. Richard ; Grothe, Rayna M. ; Crowell, Michael D. ; Francis, Dawn L. ; Grudell, April M B ; Dabade, Tushar ; Ramirez, Angelica ; Alkhatib, Mhdmaan ; Alexander, Jeffrey A. ; Kimber, Jessica ; Iyer, Prasad G ; Zinsmeister, Alan R. ; Romero, Yvonne. / The Mayo Dysphagia Questionnaire-30 : Documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. In: Dysphagia. 2010 ; Vol. 25, No. 3. pp. 221-230.
@article{a4f46e79a3a94976b87194f660b0cf16,
title = "The Mayo Dysphagia Questionnaire-30: Documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease",
abstract = "The aim of this study was to develop the Mayo Dysphagia Questionnaire-30 Day (MDQ-30), a tool to measure esophageal dysphagia, by adapting items from validated instruments for use in clinical trials, and assess its feasibility, reproducibility, and concurrent validity. Outpatients referred to endoscopy for dysphagia or seen in a specialty clinic were recruited. Feasibility testing was done to identify problematic items. Reproducibility was measured by test-retest format. Concurrent validity reflects agreement between information gathered in a structured interview versus the patients' written responses. The MDQ-30, a 28-item instrument, took 10 min (range = 5-30 min) to complete. Four hundred thirty-one outpatients [210 (49{\%}) men; mean age = 61 years] participated. Overall, most concurrent validity κ values for dysphagia were very good to excellent with a median of 0.78 (min 0.28, max 0.95). The majority of reproducibility κ values for dysphagia were moderate to excellent with a median κ value of 0.66 (min 0.07, max 1.0). Overall, concurrent validity and reproducibility κ values for gastroesophageal reflux disease (GERD) symptoms were 0.81 (95{\%} CI = 0.72, 0.91) and 0.66 (95{\%} CI = 0.55, 0.77), respectively. Individual item percent agreement was generally very good to excellent. Internal consistency was excellent. We conclude that the MDQ-30 is an easy-to-complete tool to evaluate reliably dysphagia symptoms over the last 30 days.",
keywords = "Concurrent validity, Deglutition, Deglutition disorders, Dysphagia, Questionnaire, Reproducibility",
author = "Judith McElhiney and Lohse, {Matthew R.} and Arora, {Amindra S.} and Peloquin, {Joanna M.} and Geno, {Debra M.} and Kuntz, {Melissa M.} and Enders, {Felicity T} and Mary Fredericksen and Abdalla, {Adil A.} and Yulia Khan and Talley, {Nicholas J.} and Diehl, {Nancy N.} and Beebe, {Timothy J.} and Harris, {Ann M.} and Gianrico Farrugia and Graner, {Darlene E.} and Murray, {Joseph A} and Locke, {G. Richard} and Grothe, {Rayna M.} and Crowell, {Michael D.} and Francis, {Dawn L.} and Grudell, {April M B} and Tushar Dabade and Angelica Ramirez and Mhdmaan Alkhatib and Alexander, {Jeffrey A.} and Jessica Kimber and Iyer, {Prasad G} and Zinsmeister, {Alan R.} and Yvonne Romero",
year = "2010",
month = "9",
doi = "10.1007/s00455-009-9246-8",
language = "English (US)",
volume = "25",
pages = "221--230",
journal = "Dysphagia",
issn = "0179-051X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - The Mayo Dysphagia Questionnaire-30

T2 - Documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease

AU - McElhiney, Judith

AU - Lohse, Matthew R.

AU - Arora, Amindra S.

AU - Peloquin, Joanna M.

AU - Geno, Debra M.

AU - Kuntz, Melissa M.

AU - Enders, Felicity T

AU - Fredericksen, Mary

AU - Abdalla, Adil A.

AU - Khan, Yulia

AU - Talley, Nicholas J.

AU - Diehl, Nancy N.

AU - Beebe, Timothy J.

AU - Harris, Ann M.

AU - Farrugia, Gianrico

AU - Graner, Darlene E.

AU - Murray, Joseph A

AU - Locke, G. Richard

AU - Grothe, Rayna M.

AU - Crowell, Michael D.

AU - Francis, Dawn L.

AU - Grudell, April M B

AU - Dabade, Tushar

AU - Ramirez, Angelica

AU - Alkhatib, Mhdmaan

AU - Alexander, Jeffrey A.

AU - Kimber, Jessica

AU - Iyer, Prasad G

AU - Zinsmeister, Alan R.

AU - Romero, Yvonne

PY - 2010/9

Y1 - 2010/9

N2 - The aim of this study was to develop the Mayo Dysphagia Questionnaire-30 Day (MDQ-30), a tool to measure esophageal dysphagia, by adapting items from validated instruments for use in clinical trials, and assess its feasibility, reproducibility, and concurrent validity. Outpatients referred to endoscopy for dysphagia or seen in a specialty clinic were recruited. Feasibility testing was done to identify problematic items. Reproducibility was measured by test-retest format. Concurrent validity reflects agreement between information gathered in a structured interview versus the patients' written responses. The MDQ-30, a 28-item instrument, took 10 min (range = 5-30 min) to complete. Four hundred thirty-one outpatients [210 (49%) men; mean age = 61 years] participated. Overall, most concurrent validity κ values for dysphagia were very good to excellent with a median of 0.78 (min 0.28, max 0.95). The majority of reproducibility κ values for dysphagia were moderate to excellent with a median κ value of 0.66 (min 0.07, max 1.0). Overall, concurrent validity and reproducibility κ values for gastroesophageal reflux disease (GERD) symptoms were 0.81 (95% CI = 0.72, 0.91) and 0.66 (95% CI = 0.55, 0.77), respectively. Individual item percent agreement was generally very good to excellent. Internal consistency was excellent. We conclude that the MDQ-30 is an easy-to-complete tool to evaluate reliably dysphagia symptoms over the last 30 days.

AB - The aim of this study was to develop the Mayo Dysphagia Questionnaire-30 Day (MDQ-30), a tool to measure esophageal dysphagia, by adapting items from validated instruments for use in clinical trials, and assess its feasibility, reproducibility, and concurrent validity. Outpatients referred to endoscopy for dysphagia or seen in a specialty clinic were recruited. Feasibility testing was done to identify problematic items. Reproducibility was measured by test-retest format. Concurrent validity reflects agreement between information gathered in a structured interview versus the patients' written responses. The MDQ-30, a 28-item instrument, took 10 min (range = 5-30 min) to complete. Four hundred thirty-one outpatients [210 (49%) men; mean age = 61 years] participated. Overall, most concurrent validity κ values for dysphagia were very good to excellent with a median of 0.78 (min 0.28, max 0.95). The majority of reproducibility κ values for dysphagia were moderate to excellent with a median κ value of 0.66 (min 0.07, max 1.0). Overall, concurrent validity and reproducibility κ values for gastroesophageal reflux disease (GERD) symptoms were 0.81 (95% CI = 0.72, 0.91) and 0.66 (95% CI = 0.55, 0.77), respectively. Individual item percent agreement was generally very good to excellent. Internal consistency was excellent. We conclude that the MDQ-30 is an easy-to-complete tool to evaluate reliably dysphagia symptoms over the last 30 days.

KW - Concurrent validity

KW - Deglutition

KW - Deglutition disorders

KW - Dysphagia

KW - Questionnaire

KW - Reproducibility

UR - http://www.scopus.com/inward/record.url?scp=77957314327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957314327&partnerID=8YFLogxK

U2 - 10.1007/s00455-009-9246-8

DO - 10.1007/s00455-009-9246-8

M3 - Article

C2 - 19856027

AN - SCOPUS:77957314327

VL - 25

SP - 221

EP - 230

JO - Dysphagia

JF - Dysphagia

SN - 0179-051X

IS - 3

ER -